Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

about

Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Uterine serous carcinoma: increased familial risk for lynch-associated malignancies Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.

P2860

Q30234614-13C2D2A7-3E22-405A-86D6-57C524DF45FD Q30422098-FB4DC81D-7D14-4CF6-B7E8-C43A850A9B57 Q37122297-3DFE9129-6E03-4301-859D-7D41B8EDEEF7

P2860

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

Item

http://www.wikidata.org/entity/Q51488968

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@en

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@nl

type

Item

label

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@en

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@nl

prefLabel

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@en

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

@nl

P1476

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families

@en

P2093

Colin J Stewart

http://www.w3.org/2001/XMLSchema#string

Yoland C Antill

http://www.w3.org/2001/XMLSchema#string

kConFab

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Steroid hormone receptors in breast cancer management.

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.

Cancer risks in BRCA2 mutation carriers.

P304

111-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1375/TWIN.14.2.111

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Duffy

Amanda B. Spurdle

Joanne P Young

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50807012

http://www.w3.org/2001/XMLSchema#string

P698

21425892

http://www.w3.org/2001/XMLSchema#string

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

about

P2860

P2860

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698